Graco Inc. (NYSE: GGG) — A 30%-ROE Fluid-Handling Compounder On Sale for the First Time in a Decade, If the Growth Stall Is Cyclical

Report date: 2026-07-10 · Coverage: Initiation Price (2026-07-09 close, AZI adj): ~$73.19 · Market cap: ~$12.1B · Enterprise value: ~$11.6B (net cash ~$0.57B) FY2025: revenue $2,236.6M · diluted EPS $3.08 · FCF ~$638M · GM 52.5% · OM 27.3% · ROE 31.6% · ROIC 18.5%

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information — not investment advice. The analysis that follows takes no position and carries no price target; this block is the single exception.

Verdict: HOLD / own-for-the-quality / begin accumulating a genuinely wonderful business now that it is finally reasonable — build a starter around today’s ~$73, add aggressively sub-~$68, fair-value zone ~$85–92 (~23–24x FY27 EPS, EV/EBITDA ~16–17x), and I’d stop chasing above ~$100 (~26–27x, its old peak multiple). Not a short — you do not short a 30%-ROE, net-cash Dividend Aristocrat. Conviction: medium, tilting constructive.

Tag: “The best business of the quality-industrial cohort — and, for once, the only one on sale.”

Graco is the highest-quality compounder I have looked at in the diversified/niche-industrial space this cycle, and — unusually — the cheapest versus its own history. The financial fingerprints of a real, durable moat are all here: ~52% gross margins, ~27% operating margins, ~31% ROE, ~18% ROIC (roughly twice its ~8–9% cost of capital), ~1.2x FCF/net-income conversion, and a fortress net-cash balance sheet (~$572M), earned in small, IP-and-brand-gated niches (airless sprayers, powder finishing, adhesive/sealant dispensing, specialty pumps) where Graco is #1 or #2 and its unit scale dwarfs any single-product rival. It is a 25-year Dividend Aristocrat celebrating its centennial in 2026. Critically, unlike Dover (richest-ever, 93rd–96th percentile) or ITW (85th percentile) — the two peers I most recently walked through — Graco trades at the 24th percentile of its own decade valuation range on earnings and its cheapest-ever on book, and at the lowest P/E in its quality peer group (~23.8x vs. Nordson 30.6x, IDEX 28x, Dover 25.8x) despite the highest ROE and the only net-cash sheet. The market has stripped Graco’s historical premium.

It has done so for a real reason, and that is the crux of the debate. Organic revenue has been flat-to-negative for three straight years — Q1-2026 organic volume/price was −6%, and reported “growth” is now manufactured almost entirely by acquisitions (Corob, Color Service, Valco Melton) and FX. The bear says the niches have matured, the 27%→18.5% ROIC slide is the tell, and buybacks merely offset stock-comp dilution rather than shrinking the float — a premium compounder that has quietly become an ex-growth annuity. The bull — where I lean, but not without reservation — says the stall is cyclical and concentrated: roughly half of revenue is Contractor, chained to the worst U.S. housing turnover since 1995; Industrial and Expansion bookings are already positive (backlog building, semiconductor bookings +20% every region); margins held through the entire volume air-pocket, which is direct evidence the moat is intact; and the capex cliff (facility build now done, capex $201M→$46M) has FCF running ~$600M+. At ~16x EV/EBITDA and a ~6.3% FCF yield the market is pricing in only ~2% perpetual FCF growth — a very low bar for a business that compounds book value in the high-single-to-double digits and earns 30% on equity. Framing: an abandoned quality-value name in an out-of-favor factor bucket, mid-de-rating — orderly, low idiosyncratic volatility (13%), beta 0.78, not a falling knife. The factor tape confirms it: positive Value/Quality/DividendYield loadings, negative Momentum and Growth, relative strength −16% over twelve months.

The honest caveat that keeps me at HOLD rather than BUY: organic is still negative right now, the FY2026 guide is a back-half-weighted “show-me,” and I have no proof yet that the Contractor volume inflects rather than grinds. This is a name to accumulate into weakness with a multi-year horizon, not to bang the table on before the cycle turns.

What flips me decisively bullish: two consecutive quarters of positive organic volume (a Contractor/housing inflection with operating leverage), which at ~24x would look cheap in hindsight. What flips me bearish: organic stays negative through 2027 with returns still bleeding (ROIC drifting toward the mid-teens) — confirming the stall is structural, at which point even ~24x is too much for a low-growth annuity dressed as a compounder.

📈 Stock Price Action — Five-Year Event Map

Factual price history — no recommendation, no price target. Price moves are Fact; attributed drivers are Interpretation.

Over the trailing ~65 months Graco round-tripped the COVID crash and then compounded to a fresh all-time high before de-rating: from a five-year low of ~$36.5 (Mar-2020) to an all-time high of ~$94.5 (Feb/Mar-2026), and back to ~$73.2 now — roughly a double off the 2020 low, currently ~23% below the peak. The 52-week range is ~$73–$94.5; the 200-day EMA sits ~$81.6 and price has slipped below its shorter (21-/50-day ~$75–77) EMAs, a stock in a clean multi-month downtrend. Beta is 0.78 and idiosyncratic volatility is low (~13% annualized) — a well-behaved defensive industrial whose recent decline is a multiple de-rating, not a fundamental blow-up.

Cycle narrative. (1) Graco snapped back from the COVID low on reopening capex, nearly doubling by year-end 2020. (2) The 2022 rate shock produced the period’s cleanest drawdown — a market-multiple event, not a fundamental one; earnings kept rising while the multiple fell. (3) From the 2022 low the stock compounded back toward its record on defended margins and durable cash generation. (4) It ran to a then-record ~$90.8 in early 2024. (5) A sharp ~14% single-month drop in April 2024 marked the first market acknowledgment of demand softening (the Industrial/Asia air-pocket that would show up as FY2024’s −3.8% revenue decline). (6) The stock then ranged for ~18 months before a Q4-2025 record print and a risk-on tape carried it to an all-time ~$94.5 in February/March 2026. (7) The dominant recent move is the ~23% H1-2026 de-rating: a fresh Q1-2026 organic miss (−6%), a persistent three-year organic stall, tariff noise, and a July Wolfe downgrade compressed the multiple from ~26x toward ~24x P/E (EV/EBITDA ~18.7x → ~16x) — a repricing of a premium compounder, not a broken business. (Price moves are FACT from the AZI five-year series; attributed drivers are INTERPRETATION cross-referenced to earnings dates, 8-K events, and the news feed. Note: the true adjusted all-time high is early 2026, not 2024.)

1. Executive Summary

Graco Inc. is a ~$2.24B-revenue, ~$12B-market-cap manufacturer of premium equipment used to move, measure, control, dispense, and spray fluids and powders — airless paint sprayers, industrial finishing and coating systems, adhesive/sealant dispensing, powder-coating, lubrication, and specialty process pumps. It operates through three reportable segments after a January-2025 reorganization: Contractor (~48% of sales), Industrial (~45%), and Expansion Markets (~8%). It is a focused category leader — #1 or #2 in each of its small, specialized niches — not a diversified federation, and it sells primarily through a deep global network of trained third-party distributors, layering high-margin aftermarket parts and consumables on a large installed base.

The quality is not in question; the growth is. By the financial evidence Graco is the best business in the diversified/niche-industrial cohort I have examined: ~52% gross margins, ~27% operating margins, ~31% ROE, ~18% ROIC (roughly 2x WACC), ~1.2x FCF/net-income conversion, negligible SBC (~1.5% of sales), ~4%-of-sales R&D, and a net-cash balance sheet (~$572M). The moat is real and structurally sourced (Greenwald: economies of scale in small niches + demand-side captivity via aftermarket/distribution + brand/agency pricing), and the decisive proof is that margins held through a multi-year revenue air-pocket — pricing consistently offset input and tariff costs. It is a 25-year Dividend Aristocrat marking its 100th year in 2026.

But organic growth has stalled for three years. Revenue went $2,144M (2022) → $2,196M (2023) → $2,113M (2024, down) → $2,237M (2025) — roughly +1.4%/year — and Q1-2026 organic volume/price was −6%, with reported growth manufactured by acquisitions (+5%) and FX (+3%). The stall is concentrated: Contractor (chained to the worst U.S. housing turnover since 1995) is the anchor; Industrial and Expansion Markets suffered a synchronized cyclical trough (global capex, semiconductors, EMEA project timing) but are seeing bookings recover (Industrial backlog building; semiconductor bookings +20% in every region). Returns have normalized off a 2020–21 peak (ROE 49%→32%, ROIC 27%→18.5%) as acquired goodwill and a now-complete campus build bloated invested capital while revenue went sideways.

The valuation setup is the inverse of its peers. Where Dover and ITW trade at the richest end of their own histories, Graco has been de-rated to the 24th percentile of its own decade range on earnings, its cheapest-ever on book (P/B ~4.5x), and the lowest P/E in the quality peer set (~23.8x vs. Nordson 30.6x, IDEX 28x, Dover 25.8x) — while carrying the highest ROE and the only net-cash sheet. At ~16x EV/EBITDA / ~6.3% FCF yield, embedded expectations imply only ~2% perpetual FCF growth: the growth stall is close to fully priced. Below its no-growth earnings-power value (~$38–40/share) sits genuine franchise value, and because ROIC (~31% on incremental capital historically) far exceeds WACC, that premium is analytically justified — the de-rating has compressed, not erased, Graco’s growth premium.

The forward question is singular: is the organic stall cyclical or structural? If Contractor volume inflects with housing and Industrial/Expansion bookings convert, Graco is an under-owned operating-leverage story trading at a decade-cheap multiple. If organic stays negative and returns keep bleeding, it is a low-growth annuity still priced at ~24x. Management insists “nothing is structurally wrong”; the evidence (share held/gained in Contractor, defended margins, positive bookings) supports the cyclical read, but three years is long enough that the burden of proof now sits with the top line. No recommendation or price target appears below; valuation is treated as embedded expectations and scenarios.

2. Business Overview (§7.1)

What Graco is. Founded in 1926 in Minneapolis (it began making a hand-operated grease gun for the vehicle-service trade and celebrates its centennial in April 2026), Graco designs, manufactures, and markets premium equipment that pumps, meters, mixes, controls, dispenses, and sprays a wide range of fluids and powder materials [FACT — FY2025 10-K, Item 1]. The unifying thread is precision fluid handling in demanding applications: the equipment is a small share of the customer’s total project or process cost but critical to the quality and reliability of the output (a smooth paint finish, a correctly-metered two-component foam, a precisely-dispensed bead of adhesive). Roughly 80%+ of production is in the United States, with additional manufacturing in Switzerland, Italy, China, India, Belgium, and Romania; product development is co-located with manufacturing across a dozen-plus sites, and headcount is ~4,400.

How it makes money. Graco sells primarily through third-party distributors worldwide — thousands of trained, application-expert channel partners — supplemented by selected retailers (Contractor sprayers move through home-center retail such as The Home Depot and through paint/coatings distributors) and some direct-to-end-user and OEM sales. The economic model is razor/razor-blade-adjacent: durable equipment seeds a large installed base that pulls high-margin, Graco-specific aftermarket parts, kits, and consumables (spray tips, seals, packings) over a multi-year life. The product line is deliberately high-mix/low-volume — historically ~90% of SKUs sell fewer than one unit per day yet collectively drive nearly half of sales [FACT — 2017 investor presentation, historical framing; consistent with current 10-K description]. This breadth is itself a barrier: no single competitor duplicates the whole catalog.

Segments (post-January-2025 “One Graco” reorganization). Effective January 1, 2025, Graco moved from its legacy Contractor / Industrial / Process structure to three reportable segments — Contractor, Industrial, and Expansion Markets — with the former Process (lubrication and process-transfer equipment) folded into a single global Industrial division, and newer/higher-growth ventures (semiconductor fluid handling, environmental, high-pressure/HIP valves, QED, electric motors) grouped as Expansion Markets [FACT — FY2025 10-K, Item 1 and Note 2]. Recast three-year figures:

[FACT — FY2025 10-K, Note 2 Segment Information.]

The economic center of gravity is Industrial. Though slightly smaller than Contractor in revenue, Industrial carries a ~57% gross margin and ~34% operating margin and generates roughly 52% of segment operating earnings — it is the crown jewel, and its cyclical decline (from $1,018M in 2023 to $958M in 2024, still only $997M in 2025) is the single biggest driver of the consolidated stall. Contractor is the volume anchor (~half of sales) and the only segment to grow every year (+8.4% in 2025), but its gross margin fell 2.6 points to 48.4% in 2025 on tariffs and channel/product mix, and its operating margin has eroded from 29.0% (2023) to 25.2% (2025). Expansion Markets is small (~8%) and lumpy — down 13.5% in 2024 on a semiconductor down-cycle — but the highest-optionality bucket.

Geography and concentration. By customer location FY2025 sales are roughly Americas ~60%, EMEA ~24%, Asia Pacific ~16% [FACT — 10-K]. U.S. sales have been essentially flat for three years (~$1,150–1,170M); international sales fell in 2024 and have only recovered to near-2023 levels. Customer concentration is real if long-standing: one customer in Contractor and one in Industrial each individually exceeded 10% of consolidated sales in each of the last three years [FACT — Note 2] — the Contractor customer is almost certainly a large home-center retailer; the Industrial one a major distributor. Revenue is a mix of equipment (non-recurring, cyclical) and aftermarket parts/consumables (more recurring); Graco does not break out the exact split, but the installed-base pull is what stabilizes the model between capital-equipment cycles.

Verdict (§7.1). A focused, high-margin, distributor-led niche leader with a genuinely diversified (if currently synchronized-down) set of end markets and a razor/razor-blade aftermarket underpinning. The business model is clean, cash-generative, and well understood. The one structural blemish is customer concentration in two segments; the current operational issue is that all three segments are simultaneously in a volume trough.

3. Industry Dynamics (§7.2)

Structure. Graco competes across the global fluid-handling / spray-finishing / dispensing / fluid-transfer equipment landscape — a collection of small, specialized sub-markets rather than one monolithic industry. Each niche (airless sprayers, powder-coating, two-component proportioners, AODD and specialty pumps, adhesive/sealant dispensing, lubrication) is high-mix, engineering-intensive, and consolidated at the top around one or two share leaders, with a fragmented tail of local and low-cost players. Graco’s own framing: it faces “a wide variety of competitors that vary by product, industry and geographic area… no competitor duplicates all of our products,” and competition turns on quality, reliability, innovation, engineering support, and service — not commodity price alone [FACT — FY2025 10-K, Item 1, Competition].

Competitors by segment [FACT for named firms; INTERPRETATION for relative positioning]:

• Contractor: the principal rival is the privately held Wagner Group (which owns Titan/SprayTech and TriTech), plus HomeRight and a persistent fringe of low-cost Asian imports and counterfeits. Graco (Graco and Magnum brands) is the professional/premium standard; Wagner skews stronger in DIY/prosumer.
• Industrial: Nordson (adhesive and finishing dispense — the closest premium peer), IDEX (fluidics/dispense/pumps), Dover/PSG (Wilden AODD, Almatec, Blackmer), Ingersoll Rand (ARO diaphragm pumps), SAMES/Exel, and Verder at the pump edge. In powder finishing specifically, Nordson (which owns Gema) and Wagner form a tight oligopoly with Graco.
• Expansion Markets: fragmented, application-specific players in semiconductor fluid handling, environmental, and high-pressure valves; no single dominant rival.

Regulation is light. Graco states that compliance with environmental and other laws “did not have a material effect upon capital expenditures, earnings or competitive position” [FACT — 10-K]. This is not a rate-regulated, reimbursement-driven, or licensing-gated industry; if anything, tightening VOC/coatings rules are a mild demand tailwind for efficient, low-waste application equipment.

Cyclicality. End markets are cyclical but normally staggered — Contractor tracks residential/commercial construction, repaint, and infrastructure; Industrial tracks global manufacturing capex, auto/EV, and general industrial; Expansion tracks semiconductor/electronics capex and environmental spending. In a typical cycle, weakness in one offsets strength in another. The 2024–2026 downturn is unusual precisely because construction, industrial capex, and semiconductors softened together, so the internal diversification that normally dampens amplitude failed to cushion the trough — which is exactly why an otherwise-steady compounder printed a −3.8% revenue year and a −6% organic quarter.

Marathon capital-cycle read. The niche sits in a demand-driven down/recovery phase, and — critically — the supply side is favorable and disciplined. These are small, IP- and brand-gated markets that do not attract waves of IPO-funded new entrants or a capacity arms race; barriers keep incremental supply in check. That is the Marathon condition under which a temporarily depressed leader is an opportunity rather than a value trap: no flood of new capital is coming to compete away returns, and Graco’s own capex cycle has just peaked and rolled over (major U.S./Switzerland/Romania facility build-out completed 2023–24; capex $201M→$46M), a favorable asset-growth signal as cash redeploys to dividends and buybacks. The risk to this read is a genuinely prolonged demand recession, not supply-side disruption.

Verdict (§7.2): structurally good (attractive). Small, defensible, high-margin niches; rational and disciplined supply; no disruptive-technology threat; low regulatory burden. Demand cyclicality is uncomfortable but self-correcting, and the current weakness is cyclical rather than structural — the capital cycle favors the entrenched incumbent.

4. Competitive Position (§4 / §7.3)

The moat, named. In Greenwald’s taxonomy Graco’s advantage rests on the strongest available pairing — economies of scale in niche markets + demand-side customer captivity — reinforced by intangibles (brand/reputation) and a hard-to-replicate distribution network. The scale is applied to small markets, which is where scale advantages are most durable: “market growth is the enemy of scale advantages,” and Graco’s slow-growing niches protect rather than threaten its position.

• Scale-in-niche. In each sub-market — airless sprayers, powder coating, finishing/adhesive dispense — Graco’s unit volume dwarfs any single-product competitor, spreading a ~$82M/year (~4% of sales) R&D budget and specialized tooling/manufacturing over a share base no niche entrant can match. The relevant market is the application, not “pumps” broadly, and within the application Graco is dominant.
• Captivity / switching costs. The installed base of durable Graco equipment pulls Graco-specific aftermarket parts and consumables at high margin; contractors and OEMs are trained on Graco, value uptime, and will not risk an unproven substitute mid-job (search plus switching costs). The distributor network is a second captivity layer — thousands of trained, application-expert partners are expensive to replicate, and a would-be rival must build the channel and the installed base simultaneously.
• Brand / agency pricing. The Graco name is the professional standard, and the purchase decision is typically made by the pro or the distributor — not the ultimate payer — an “agency relationship” that confers durable pricing power (a Marathon value-in-growth signature).

Financial proof (the test that matters). A moat that cannot be tied to a financial outcome is not a moat. Graco’s ~52% consolidated gross margin (Industrial ~57%), ~27% operating margin, ~31% ROE, and ~18% ROIC have been sustained for well over a decade — far above the Greenwald 15–25% ROIC threshold for a genuine barrier — and, decisively, margins held through the 2024–2026 volume trough (Industrial operating margin 33.6% in 2025 vs. 35.0% two years earlier, despite a mid-single-digit sales decline). In Q1-2026, price realization offset a ~$4M Contractor tariff hit and segment operating margin held. Margin stability through a demand air-pocket is the cleanest available evidence of pricing power, and pricing power is the moat made visible.

Market-share stability. There is no evidence of the >5-point share swings that would signal a breached barrier. Graco’s leadership in airless sprayers, powder, and finishing dispense has been stable for years; Contractor grew +8.4% in 2025 while construction was weak — consistent with share hold or gain, not erosion. The stall is end-market volume, not competitive displacement.

Benchmark against peers. Versus Nordson — the closest premium peer — Graco shows comparable ~55%+ gross margins and mid-20s%+ operating margins but on a cleaner, net-cash balance sheet and with a higher ROE and less goodwill (Nordson is a more levered roll-up). Versus IDEX (~44% gross margin, low-teens ROIC) and Dover/PSG and Ingersoll Rand ARO (broad federations, high-30s/low-40s gross margins), Graco’s focused-niche economics are structurally superior in the overlapping dispense/AODD applications. Versus Wagner (private), Graco has the deeper professional/industrial breadth, distributor depth, and aftermarket pull.

Verdict (§7.3): a real structural moat, moderate width — not merely an “elite operator.” The distinction matters: Graco’s returns rest on identifiable, defensible structural sources (niche scale + installed-base/aftermarket captivity + distribution + brand/agency pricing) that survive management and are proven by margin/ROIC stability through a trough and by price consistently beating cost. Three caveats keep it “moderate” rather than “wide”: (1) the markets are small, so the absolute dollar size of the moat is capped; (2) Contractor gross margin slipped 2.6 points in 2025 — pricing power is strong but not infinite; (3) ROE/ROIC have normalized off a 2020–21 peak (49%→31% ROE, 27%→18.5% ROIC) as mix shifted and the capex-heavy expansion diluted returns — the moat is intact, but the return on it has come down.

5. Growth History and Forward Opportunities (§7.4)

History. Revenue compounded strongly out of COVID — $1,650M (2020) → $1,988M (2021, +20%) → $2,144M (2022, +8%) — and then stalled: $2,196M (2023, +2%) → $2,113M (2024, −3.8%) → $2,237M (2025, +5.9%), or roughly +1.4%/year across 2022–2025. Diluted EPS nonetheless rose from $2.66 (2022) to $3.08 (2025), carried by defended margins, modest buybacks, and a lower share count — EPS growth without volume growth, the same pattern seen at ITW and Dover.

The stall, decomposed. The critical fact is that the three-year plateau is not broad decay but concentrated cyclical weakness masking a still-growing Contractor:

• Contractor grew every year ($985.7M → $988.9M → $1,071.9M), +8.4% in 2025, on resilient repaint and pro-paint demand plus the Corob acquisition.
• Industrial fell from $1,018M (2023) to $958M (2024, −5.9%) and has only recovered to $997M (2025) — still below 2023 — on global manufacturing-capex softness and EMEA/APAC project-timing.
• Expansion Markets fell from $192M (2023) to $166M (2024, −13.5%) and is stuck at $168M (2025) on a semiconductor down-cycle.

So FY2024’s −3.8% decline was entirely Industrial and Expansion; Contractor carried the franchise. The Q1-2026 tell confirms it is still cyclical: consolidated sales +2%, but decomposed into volume/price −6%, acquisitions +5%, currency +3% — organic volume negative across all three segments, with Asia Pacific volume −12% and EMEA industrial −22% ex-acquisitions. Reported growth is being manufactured by M&A and FX, not underlying demand.

Forward opportunities.

• Cyclical recovery (the swing factor). Contractor is the operating-leverage call: ~half of revenue chained to U.S. housing turnover, which management describes as the “lowest home sales since 1995.” A mortgage-rate/affordability normalization would lift repaint and pro-paint volumes with high incremental margins. Industrial bookings are already positive (+5% in Q1-2026, backlog up ~$23M plus another ~$21M into April), which management frames as a conversion-timing miss rather than lost demand. Expansion’s semiconductor bookings are +20% in every region off a tough comp.
• M&A adjacencies. Graco’s algorithm targets ~10% top-line growth with ~1/3 from acquisitions; ~30% of 2025 revenue is acquired (since the 2012 Gema deal). Recent tuck-ins extend into color/paint dispensing (Corob, Color Service, Radia) and, with the ~$447M Valco Melton deal (adhesive dispensing), directly into Nordson’s turf.
• Expansion Markets optionality. Semiconductor fluid handling, environmental, and electric-motor ventures are small today but high-growth; electric-motor upfront license fees ($7M in 2025) hint at a licensing-royalty model, though it is lumpy and unproven as recurring.
• New-product cadence. The ~4%-of-sales R&D funds a steady drumbeat of new SKUs that refresh the installed base and defend share — the organic engine when end markets cooperate.

Verdict (§7.4): high-quality growth, currently absent. When it comes, Graco’s growth is genuinely value-creating (high-margin, high-ROIC, aftermarket-pulling). But it has not come organically for three years, and the near-term reacceleration depends on a Contractor/housing inflection that is forecast, not yet observed. This is the thesis’s central uncertainty — quality of growth is high; quantity and timing are the open questions.

6. Financial Quality (§7.5)

Elite, cash-backed economics on a stalled top line. The margin structure is the headline: gross margin has held in a 49–53% band for a decade (52.5% in FY2025), operating margin 25.9–29.4% (27.3%), EBITDA margin ~29–33% (32.1%) — and, tellingly, these held through the revenue decline, direct evidence of pricing power. Net income rose from $330M (2020) to $522M (2025); diluted EPS from $1.92 to $3.08.

Returns are elite but have normalized. ROE was 31.6% and ROIC 18.5% in FY2025 (return-on-capital ~31%, ROA 16.3%) — ROIC is roughly 2x an ~8–9% WACC, comfortably value-creating. But both have de-rated off a 2020–21 peak: ROE 49%→32%, ROIC 27%→18.5%. The cause is not margin erosion (margins held) but invested-capital inflation — acquired goodwill and intangibles rose from ~$499M (FY2023) to ~$893M (FY2025) via the Corob/Color Service deals, and the 2021–23 campus build-out added fixed assets, all while revenue went sideways. The moat is intact; the incremental return on recently deployed capital has not yet earned the legacy 27%.

Quality of earnings: high. FY2025 cash from operations was $683.6M vs. net income $521.8M (CFO/NI 1.31x), and free cash flow (CFO less ~$46M capex) was ~$638M (FCF/NI 1.22x) — net income is fully cash-backed and then some. Over five years CFO/NI ran ~1.0–1.3x every year except FY2022 (0.82x), when a supply-chain-era inventory build (+$96M) drained working capital; that has fully reversed, with inventory a source of cash in 2023–2025 (~$140M released from the 2022 peak under the One Graco initiative). Stock-based comp is modest (~$34M, ~1.5% of sales) and not a cash distortion. D&A has risen ($55M in 2020 → $107M in 2025) with acquired-intangible amortization and the campus.

Two normalization flags for valuation [ASSUMPTION/OPEN QUESTION]: (a) the effective tax rate was abnormally low in 2020–21 (~11.8%/13.5%) versus ~18.6% in FY2025 — normalize when comparing 2021 EPS to today; (b) non-operating items in 2020 (~$35M impairment plus other non-cash) and 2023 (~$33–37M other-income) modestly distort those base years, though pretax margins stayed ~28% so run-rate is not materially inflated. Also debunk the ROIC-reported “92% incremental operating margin” (FY2024) — an artifact of a falling revenue denominator; Graco’s true through-cycle incremental margin is ~35–45%, consistent with a 52% gross margin.

Book value reconciled. FY2025 shareholders’ equity was $2,653.9M over 165.15M shares = BVPS ~$16.07, so at $73.19 P/B is ~4.5x (the AZI figure; a third-party feed’s 8.4x is erroneous and discarded). That ~4.5x is the stock’s cheapest-ever on its own history (0.02 percentile) because equity has compounded quickly while the multiple de-rated — though 4.5x book on a 31% ROE business is not “cheap” in absolute terms.

Balance sheet: fortress. Cash $624M against total debt $51.6M → net cash ~$572M, net-debt/EBITDA −0.83x, interest coverage >200x, current ratio 3.15x. The pension liability has been managed down to $87M (from $185M in 2020); leases are small (~$27M); tangible common equity remains ~74% of equity despite the goodwill build.

Verdict (§7.5): do economics improve with scale? Yes — margins scale and hold, but incremental returns on the latest capital have not. This is a high-quality, cash-generative, fortress-balance-sheet compounder whose returns have normalized from hyper-elite to merely-elite as growth stalled and capital was deployed into goodwill and facilities. Not deteriorating; no longer hyper-returning.

7. Capital Allocation (§7.6)

Dividends — a 25-year Aristocrat. Graco has raised its dividend for 25 consecutive years [FACT] — declared DPS $0.96 (2023) → $1.04 (2024) → $1.12 (2025), with the quarterly rate lifted from $0.275 to $0.295 for 2026 (+7.3%). Cash dividends were ~$183M in FY2025 (~$195M planned for 2026). Payout is conservative at ~35% of EPS / ~27–29% of FCF (~3.7x covered) — safe and growing, with ample room to keep raising, but immaterial as a total-return driver at a ~1.5% yield.

Buybacks — dilution-offsetting, not float-shrinking. FY2025 gross repurchases were ~$423M (~$380M net of option proceeds); FY2024 was actually net issuance (grants exceeded buybacks). Share count has barely moved — 168.6M (2020) → 165.2M (2025), only ~2% net reduction over five years — because equity grants continuously dilute. A new repurchase authorization was approved in early 2026 alongside the dividend increase. Interpretation: buybacks are opportunistic and mostly neutralize SBC dilution rather than compound per-share value; per-share growth therefore leans on organic growth, which has stalled.

M&A — disciplined tuck-ins, stepping up. FY2025 deals: Corob S.p.A. (~€230M plus up to €30M contingent — automatic paint/coatings tinting and dispensing) and Color Service s.r.l. (~$77M — gravimetric color dosing). FY2024 acquisitions were ~$242M. The pending Valco Melton deal (announced May 2026, ~$447M, ~14x EBITDA — precision adhesive dispensing/quality-assurance) is the largest recent transaction and pushes Graco directly into Nordson-adjacent adhesive dispensing. Prices look full (Corob ~2–3x sales; Valco ~14x EBITDA) but not reckless for niche market-leaders. The Capital Returns caveat: this goodwill build is precisely what dragged ROIC from 27% to 18.5%, so the deals must earn their multiples for the return profile to recover.

R&D and capex. Product-development spend is steady at ~$82M (~4% of sales), funding the new-product cadence that underpins the moat. Capex has normalized sharply — $201M (2022) → $185M (2023) → $107M (2024) → $45.7M (2025) — as the multi-year campus/facility build-out completed; the 2026 plan is ~$100M, implying a sustainable FCF run-rate of ~$600M+.

Incentives and insiders. CEO Mark Sheahan’s annual bonus is keyed to Net Sales and Incentive EPS; long-term incentives are options plus performance shares over overlapping four-year vesting, with clawbacks adopted in 2023. The governance gap: there is no explicit ROIC/return-on-capital metric — a notable omission for a company whose central issue is falling incremental returns on acquired capital; the comp design rewards top-line and EPS growth (achievable via M&A and buybacks) without policing ROIC dilution. Graco is not founder-controlled; ownership is grant-driven with modest personal stakes. Recent Form 4 activity is routine grants with no discretionary open-market selling, and one small conviction signal — director Andrea Simon bought 1,240 shares at ~$80.53 in April 2026.

Verdict (§7.6): intelligent, conservative, shareholder-friendly — two caveats short of excellent. A 25-year dividend-growth streak, a net-cash fortress, disciplined (if full-priced) tuck-in M&A, steady R&D, and a now-normalized capex base throwing off ~$600M FCF. What keeps it from “excellent”: buybacks that offset rather than shrink the float, and an M&A/goodwill build that diluted ROIC — unpoliced by a comp structure that omits a capital-efficiency metric. Good stewards deploying into sensible adjacencies; the open question is whether those adjacencies restore the return profile.

8. Changes and Headwinds — Last Two Years (§7.7)

Strategic / structural.

• “One Graco” reorganization (end-2024 into 2025): consolidated operations under single leadership and realigned reporting into Contractor / Industrial / Expansion Markets (Process folded into Industrial). It drove ~$15M+ of annual cost-out, a ~$140M inventory reduction, >100% FCF conversion, and strong Industrial incremental margins — a genuine, durable self-help win.
• M&A cadence: Corob (Sep-2024, Contractor dispensing), Color Service (Jul-2025, Industrial powder/color), Radia/Red Devil (Nov-2025, Contractor color), and Valco Melton (announced May-2026, ~$447M/~14x EBITDA, Industrial adhesive dispensing; expected to close fiscal Q3-2026). This reliably supplies the “~1/3 of growth from M&A” algorithm and extends the franchise into adhesive dispensing.
• Leadership: an orderly, telegraphed CFO succession — David Lowe (30+ years) retiring, Sanjiv Gupta (ex-GM International CFO, deep ops/supply-chain background) appointed CFO effective April 2026 — plus a new director (Hedlund) effective September 2026. CEO Sheahan (since 2021) continues.

Operational headwinds.

• The three-year organic stall centered on Contractor/construction (worst U.S. housing turnover since 1995), compounded by a synchronized Industrial and semiconductor trough. Q1-2026 organic −6% and a back-half-weighted FY2026 “show-me” guide (low-single-digit organic, mid-single including M&A).
• Tariffs: ~$14M in FY2025 (~60bps of gross margin), ~$7M in Q1-2026 — managed via pricing (~1.0–1.5% for 2026, plus a rare interim mid-2025 increase) and planned refund claims; ~80%+ U.S. manufacturing limits exposure. The Section 232 shift from raw-metal to full-imported-component value is a watch item.
• Middle East conflict: an indirect input-cost/logistics risk (petroleum-based paints/adhesives; ~$35M/year of Middle East sales) — no material demand hit yet.
• Market sentiment: a July-2026 Wolfe downgrade to Peer Perform on growth concerns; consensus price targets trimmed — sell-side capitulation into the de-rating rather than a company event.

Verdict (§7.7): neutral-to-modestly-strengthening on quality, but not on growth. The franchise and balance sheet are getting better (One Graco margins/FCF, net cash, disciplined M&A, orderly succession); the top-line engine has not re-accelerated. Reported growth is increasingly acquisition/FX-manufactured while organic has been flat-to-negative for three years — the central bear point. M&A is masking, not curing, the organic-volume problem. The thesis hinges on whether housing/industrial volume inflects (operating-leverage upside) or the organic stall proves structural (further de-rating of a premium name). Constructive-but-show-me.

9. Risk Analysis (§7.8)

Overall risk read: the dominant risk is analytical (structural vs. cyclical stall) and valuation (a premium multiple with more room to compress), not balance-sheet or franchise risk. The net-cash, no-leverage, diversified profile makes a permanent capital impairment highly unlikely; the realistic downside is a lower multiple on a stalled top line, not a blow-up.

10. Valuation Discussion (§7.9)

Where it trades. At ~$73.19 (~166.7M shares, ~$12.1B market cap, net cash ~$0.57B, EV ~$11.6B) against TTM sales ~$2.24B, EBITDA ~$716M, EBIT ~$604M, FCF ~$728M, and EPS ~$3.07: P/E ~23.8x, EV/EBITDA ~16.2x, EV/EBIT ~19.2x, EV/Sales ~5.2x, EV/FCF ~15.9x (FCF yield ~6.3%), dividend yield ~1.5%. (A brief’s ~18.2x EV/EBITDA reflects the Q1-2026 snapshot at ~$84; at the current $73 it is ~16.2x.)

Own-history context — cheap for Graco. On the AZI own-history percentiles Graco sits at the 24th percentile on earnings, the 49th on sales, and the 0.02 (cheapest-ever) percentile on book, composite ~24.5th. The multi-year de-rating is real: P/E ran 37x (2020) → 31x (2021) → ~24x now; EV/EBITDA 22–25x (2020–21) → ~16x now. The stock has surrendered essentially all of its historical premium. (Read P/E and EV/EBITDA rather than the P/B percentile in isolation — the low, asset-light book makes P/B optically extreme.)

Comp set — the cheapest high-quality name in the group.

[ROIC TTM data, cross-checked to filings.] Graco carries the highest ROE (~32%) and margins (tied with Nordson on EBITDA, well above IDEX/Dover) and the only net-cash balance sheet, yet the lowest P/E in the quality peer set, and a mid-pack EV/EBITDA. On quality-adjusted metrics it is the cheapest premium name in the group — the de-rating has removed its historical premium relative to peers, not only relative to itself.

Embedded expectations. At EV/FCF ~15.9x (FCF yield 6.3%), a Gordon reverse with a cost of equity ~8.5% (beta 0.78, net cash) implies the market is pricing ~2% perpetual FCF growth. For a business that has compounded book value and FCF in the high-single-to-double digits with 30%+ ROIC, ~2% embedded growth is a low bar — the price now underwrites the growth stall persisting near-permanently. That is justified if short-cycle demand stays stalled and organic growth structurally slows; it is an overshoot if the stall is cyclical.

Earnings-power value vs. growth value. NOPAT ~$495M (EBIT $604M × (1−18%)) divided by an ~8.5% WACC gives a no-growth EPV of ~$5.8B, plus net cash ~$0.6B ≈ ~$38–40/share of earnings-power value. Current ~$73 therefore embeds ~$33–35/share (~45% of price) of franchise/growth value. Because ROIC (~31% on incremental capital historically) far exceeds WACC, Graco’s growth genuinely creates value, so paying a premium to EPV is analytically justified (unlike a no-moat name that should trade near EPV). The de-rating has compressed, not eliminated, Graco’s growth premium.

Scenarios (2–3-year analytical value ranges — NO price target; all ASSUMPTION):

• Bear (~$56–62): organic stays flat-to-negative (short-cycle recession, tariff drag), FY28 EPS ~flat $3.00–3.15, multiple compresses toward broad-industrial ~18–20x as the quality premium fully de-rates (EV/EBITDA ~13–14x on flat EBITDA).
• Base (~$85–92): mid-single-digit organic resumes 2027+, steady bolt-on M&A, EPS compounds ~6–8%/yr to ~$3.65–3.85 by FY28, exit P/E 23–24x (peer- and mid-history-consistent; EV/EBITDA ~16–17x on ~$800M EBITDA).
• Bull (~$107–116): cyclical short-cycle recovery + accretive deployment of the ~$0.6B net cash + buybacks, EPS ~$4.10–4.30 by FY28, quality premium restored to 26–27x (EV/EBITDA ~19–20x, its 2020–21 range).

Verdict (§7.9). Graco is the cheapest high-quality, net-cash name in its peer set, priced for the growth stall to persist. The embedded ~2% FCF growth and the ~1.9x price-to-EPV ratio say the market has discounted the stall but not written off the franchise. The valuation is reasonable-to-attractive for the quality — not a deep-value bargain in absolute terms (still ~24x P/E, ~4.5x book), but genuinely cheap versus its own decade and versus peers.

11. Variant Perception (§7.10)

Consensus. After a July Wolfe downgrade and trimmed targets, the sell-side view has converged on “great business, but the growth has stalled for three years and the premium multiple is unjustified until organic inflects” — a Peer-Perform holding pattern. The stock’s factor positioning corroborates a market that has given up on it: positive Value, Quality, and DividendYield loadings, negative Momentum and Growth, relative strength −16% over twelve months, a −0.91 one-year Sharpe, and negative alpha (−0.19) — an abandoned quality-value name in an out-of-favor factor bucket. Crucially, the de-rating is orderly (idiosyncratic vol ~13%, beta 0.78, drawdown multiple-driven), i.e., a re-rating of a good business, not a falling knife pricing in a fundamental crisis.

Strongest bull case. The stall is cyclical and concentrated, not structural. Roughly half of revenue (Contractor) is chained to the worst U.S. housing turnover in three decades — a self-correcting cycle with high operating leverage on the way up. Industrial and Expansion bookings are already positive (backlog building; semiconductor bookings +20% every region), suggesting a demand conversion problem, not demand loss. Margins held through the entire volume trough — proof the moat is intact — and the capex cliff has FCF at ~$600M+. At the 24th percentile of its own history, the lowest P/E among quality peers, and only ~2% embedded FCF growth, an investor is paying a decade-cheap price for a 30%-ROE, net-cash compounder and getting the cyclical recovery as a free option.

Strongest bear case. The stall is structural maturity dressed up as a cycle. Three years is a long time; the niches may simply be mature, with pricing power (Contractor gross margin already slipping) and share both near their ceilings. Returns tell the story — ROIC has fallen from 27% to 18.5% as management bought ~$500M+ of goodwill (at full multiples) to manufacture growth the core could not produce organically, and buybacks merely offset dilution. Strip the M&A and FX and Graco is an ex-growth annuity earning declining incremental returns, still priced at ~24x earnings and ~4.5x book — a premium that a low-single-digit grower does not deserve, with a de-rating toward ~18–20x (a ~20–25% drawdown) the natural resolution.

The 3–5 assumptions that matter most:

1. Is the Contractor/housing weakness cyclical or a new normal? (Bull: cyclical; bear: affordability-impaired demand is structurally lower.)
2. Do Industrial/Expansion bookings convert to organic revenue in 2H-2026/2027? (The backlog is the near-term proof point.)
3. Does ROIC re-inflect as acquired businesses mature, or keep bleeding toward the mid-teens?
4. Does the market grant a quality-compounder multiple (23–27x) or re-rate to a low-growth-industrial multiple (18–20x)?
5. Can pricing power hold (Contractor gross-margin trajectory) as tariffs and mix pressure the highest-volume segment?

What would falsify each side. Bull falsified: two more quarters of negative organic with positive-and-converting bookings, i.e., the backlog fails to translate — the “conversion timing” excuse breaks. Bear falsified: a return to positive organic volume (not price/M&A) for two consecutive quarters, confirming the cycle — not the franchise — was the problem.

Net variant view. Consensus is extrapolating a three-year stall into perpetuity and pricing Graco as a stalled cyclical; the moat evidence (margin stability, share hold/gain, positive bookings) and the balance sheet say it is a temporarily-depressed compounder. The disagreement is entirely about time — how long the organic trough lasts — and the price already compensates for a fairly long one.

12. Fact vs. Interpretation

13. Open Questions

1. Cyclical vs. structural — the whole thesis. How many more quarters of negative organic before the “cyclical” read is untenable? The 2H-2026 backlog conversion is the near-term tell.
2. Contractor/housing — does U.S. home turnover and repaint demand inflect in 2026–2027, and how much operating leverage does Contractor actually have on the way up?
3. ROIC trajectory — do the Corob/Color Service/Valco Melton acquisitions earn their (full) multiples and re-inflate ROIC, or is 18.5% the new normal?
4. Aftermarket / recurring mix — Graco does not disclose the equipment-vs-consumables split; how much of revenue is genuinely recurring (and thus how defensive is the trough)?
5. Valco Melton integration — a ~14x-EBITDA, Nordson-overlapping deal; accretion, synergy, and whether it signals larger, pricier M&A ahead.
6. Section 232 escalation — the shift to full-component-value tariffs and its net margin impact after refunds.
7. 2020/2023 non-operating items — exact nature/size for clean base-year normalization.
8. Electric-motor licensing — is the lumpy ETM upfront-license revenue ($7M in 2025) a durable royalty stream or one-off optionality?

14. What Must Be True (§14)

Bull case — what must be true:

1. The organic stall is cyclical: Contractor volume inflects with a housing/affordability normalization, and Industrial/Expansion backlog converts to positive organic revenue by 2H-2026/2027.
2. Margins and pricing power hold (Contractor gross margin stabilizes), confirming the moat is intact through the cycle.
3. ROIC re-inflects toward the low-20s as acquired businesses mature and the capex base stays normalized, throwing off ~$600M+ FCF.
4. The market re-grants a quality-compounder multiple (23–27x) as organic growth returns.

Falsification test: two consecutive quarters of positive organic volume (not price/M&A/FX) would confirm the bull; conversely, two more quarters of negative organic with backlog failing to convert falsifies it — the “timing” excuse breaks and the stall looks structural.

Bear case — what must be true:

1. The niches are mature: organic growth is structurally low-single-digit at best, and pricing/share are near their ceilings.
2. Management keeps buying growth at full multiples (goodwill up, ROIC drifting toward the mid-teens), with buybacks only offsetting dilution.
3. The market re-rates Graco to a low-growth-industrial multiple (18–20x), a ~20–25% de-rating from here.

Falsification test: a sustained return to positive organic volume for two consecutive quarters falsifies the bear (the cycle, not the franchise, was the problem); persistent negative organic with rising goodwill and flat-to-down ROIC confirms it.

Synthesis. The two cases share the same facts and differ only on duration. Because the balance sheet is a net-cash fortress and the moat is proven by margin stability, the realistic bear outcome is a lower multiple on a stalled top line (~$56–62), not a permanent impairment — and the price already discounts a fairly long trough. The asymmetry favors the patient accumulator, provided the horizon is measured in years and the cyclical inflection eventually arrives.

15. Source Appendix

(Primary sources below.)

• Graco Inc. FY2025 Form 10-K (filed 2026-02-17, period ended 2025-12-26) — Item 1 Business, Item 7 MD&A, Note 2 Segment Information, financial statements.
• Graco FY2024 / FY2023 Form 10-K — segment recast, multi-year trends.
• Graco Q1-2026 / Q3-2025 / Q4-2025 10-Qs & earnings — organic decomposition, segment bookings, pricing, tariffs.
• Graco earnings-call transcripts — Q1-2026 (2026-04-23), Q4-2025 (2026-01-27), Q3-2025 (2025-10-23) — via ROIC.ai.
• Graco DEF 14A proxy (2026-04-02) — executive compensation metrics, incentive design.
• Form 8-Ks — CFO succession (2026-03-02), Valco Melton acquisition (2026-05-21), director appointment (2026-06-15), dividend increase + buyback authorization (2026-02-13).
• Form 4 corpus (2024–2026) — insider transaction read (routine grants; one director open-market buy).
• ROIC.ai — profitability ratios, enterprise value, valuation multiples (GGG, NDSN, IEX, DOV); reconciled to filings.
• AZI — price history CSV (five-year event map), valuation-index own-history percentiles, news feed (Wolfe downgrade).
• FactorsToday — factor loadings, stock-info, related-stocks, specific vol.
• Business-quality / capital-cycle frameworks — Greenwald & Kahn, Competition Demystified; Marathon, Capital Returns (investment-research-frameworks skill).
• Third-party press: Wolfe downgrade (investing.com, 2026-07-09); Valco Melton (BusinessWire, 2026-05-13); dividend/buyback (Investing.com, 2026-02).

Facts are cited to primary filings where possible; interpretations and assumptions are labeled as such throughout. Management commentary is treated as hypothesis and validated against filings, financials, and external data.

APPENDIX A — Standard Diligence Questionnaire — Graco Inc. (NYSE: GGG)

Supplemental to the analysis. Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The dominant question, voiced directly on the Q1-2026 call (BNP’s Buscaglia): “Three years in and the top line can’t grow — is there something structural?” [FACT — transcript]. Everything else flows from it: Is the organic stall cyclical (housing/capex trough) or structural (mature niches)? Is management manufacturing growth through M&A and FX to mask a stalled core? Why has ROIC fallen from 27% to 18.5%? Does a premium ~24x multiple survive if organic stays negative? Is Contractor’s gross-margin slip (−2.6pts in 2025) the start of pricing-power erosion or a one-off tariff/mix effect? Secondary questions: aftermarket/recurring mix (undisclosed), the Valco Melton multiple (~14x), and whether the electric-motor licensing model is durable.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: a cyclical low-to-mid. Organic volume has been negative for three years with all three segments simultaneously in a trough (construction, industrial capex, semiconductors) — an unusual synchronized down-cycle. Absolute EPS ($3.08) is at a record, but that is margin/M&A-driven; underlying volume is depressed. Normalized mid-cycle earnings are plausibly higher than the current run-rate if end markets recover.

Driven by external environment or internal actions? Both. The revenue stall is external (end-market demand); the defended margins, >100% FCF conversion, and cost-out are internal (the One Graco self-help program).

How stable are revenues? Moderately — a razor/razor-blade aftermarket on a large installed base stabilizes the base, but equipment sales are cyclical. FY2024 fell −3.8%; the range across 2022–2025 was $2,113–2,237M (~±3%).

Outlook for products/services? Steady structural demand for fluid-handling/spray/dispense equipment; a mild VOC-regulation tailwind for efficient application. Near-term hinges on housing (Contractor) and capex (Industrial/Expansion) recovery.

How big will this market be — growing, shrinking, domestic or international? Small, slow-growing, defensible niches; ~60% Americas / ~24% EMEA / ~16% Asia Pacific. Low-single-digit structural growth, augmented by M&A into adjacencies (color/adhesive dispensing).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Stable. No evidence of new-entrant waves or >5pt share swings; disciplined supply side (Marathon-favorable). Graco held/gained Contractor share (+8.4% in 2025) through a weak market.

How profitable is the business (ROIC, ROE)? Elite: ROE 31.6%, ROIC 18.5% (~2x WACC), return-on-capital ~31%. Down from a 2020–21 peak (49% ROE / 27% ROIC) on goodwill and capex inflation, but still comfortably value-creating.

How profitable is the industry — competitors, barriers? The premium niches are high-margin (Graco ~52% GM, Nordson ~55%); barriers are niche scale, installed-base captivity, distribution depth, and brand — moderate but real.

Can the business be easily understood? Yes — a focused equipment maker with a razor/razor-blade aftermarket; far simpler than a diversified federation.

Can it be undermined by foreign low-cost labor? Partially at the DIY/prosumer fringe (low-cost Asian sprayer imports/counterfeits), but the professional/industrial core is protected by engineering, reliability, distribution, and aftermarket lock-in. ~80%+ US manufacturing.

Do brands matter? Yes — Graco/Magnum are the professional standard; the pro/distributor (agency) chooses the tool, conferring pricing power.

Nature of competition? Quality, reliability, innovation, engineering support, service — not commodity price. Competitors: Wagner (Contractor), Nordson/Gema, IDEX, Dover/PSG, Ingersoll Rand ARO (Industrial).

Customers’ switching costs? Real: training on Graco, Graco-specific parts/consumables, uptime risk, and distributor relationships create search + switching costs.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The brand, installed base, distributor network, and aftermarket annuity are economic assets not capitalized — the source of the ~4.5x book value.

Off-balance-sheet liabilities? Minimal — small operating leases (~$27M) and a well-managed pension ($87M liability, down from $185M). No material contingencies flagged.

How conservative is the accounting? Conservative and high-quality: CFO/NI ~1.31x, FCF/NI ~1.22x, modest SBC (~1.5% of sales), no evident aggressive revenue recognition. Two minor normalization flags (low 2020–21 tax rate; small 2020/2023 non-operating items).

How capex-hungry? Not — capex normalized to ~$46M (2025) after the 2021–23 campus build; ~$100M plan for 2026 is ~4.5% of sales. Sustainable FCF ~$600M+.

Capital Allocation & Management

How much FCF, and how is it used? ~$638M FY2025 FCF. Priority: organic capex → disciplined M&A → dividend → opportunistic buyback. FY2025 uses: buybacks ~$423M, dividends $183M, acquisitions $135M, capex $46M.

Significant acquisitions recently? Corob (~€230M), Color Service (~$77M), Radia/Red Devil (2025); Valco Melton (~$447M/~14x EBITDA, announced May-2026). On-strategy color/adhesive-dispensing adjacencies; prices full but not reckless.

Buying back shares? Modestly — ~2% net share reduction over five years; buybacks largely offset SBC dilution rather than shrink the float. New authorization approved early 2026.

Issuing large amounts of stock to insiders? No — routine equity grants (~1.5% of sales SBC); not founder-controlled.

Compensation policy? Cash bonus on Net Sales + Incentive EPS; long-term options + performance shares over 4-year vesting; clawbacks adopted. Caveat: no ROIC/return-on-capital metric — a governance gap given falling returns on deployed capital.

Motivations of management? Professional stewards; orderly telegraphed CFO succession (Gupta from GM); modest grant-driven ownership; benign insider activity with one small director open-market buy.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a U.S. C-corporation common stock (NYSE: GGG); standard 1099 treatment.

Dividend policy? 25-year Dividend Aristocrat; DPS $1.12 (2025), quarterly raised +7.3% to $0.295 for 2026; ~35% payout, ~1.5% yield, ~3.7x FCF-covered.

How profitable? Very — 52% GM, 27% OM, 23% net margin, 31% ROE.

Net income diverging from cash from operations? No — CFO exceeds NI (1.31x); earnings are cash-backed.

Risks & Downside

What factors would cause the stock to decline? A prolonged organic stall proving structural; continued housing/capex weakness; multiple de-rating toward broad-industrial 18–20x; M&A misallocation; tariff escalation.

Risk of catastrophic loss? Very low — net cash, no leverage, diversified end markets, no single-product dependence.

Chance of a total loss? Effectively nil.

Recent News & Events

Has the business environment changed recently? Yes negatively on demand (three-year organic stall, Q1-2026 −6%, Wolfe downgrade July-2026) but positively on self-help (One Graco margins/FCF, net cash) and M&A cadence (Valco Melton).

Significant acquisitions? Valco Melton (~$447M) — largest recent deal, adhesive dispensing.

Change in accounting policies? Segment reorganization (Contractor/Industrial/Expansion Markets) effective Jan-2025 — reporting change, not accounting-principle change.

Recent changes — new markets, facilities, management? New campus/facility build completed (capex normalized); CFO succession (Gupta, April-2026); new director (Hedlund, Sept-2026); centennial April-2026.

APPENDIX B — Source Appendix — Graco Inc. (NYSE: GGG)

Primary sources prioritized. Facts cited to filings where possible; interpretations/assumptions labeled in the memo. Access date: 2026-07-10.

Primary — SEC Filings (Graco Inc., CIK 0000042888)

• FY2025 Form 10-K (filed 2026-02-17; fiscal year ended 2025-12-26) — Item 1 Business (segments, competition, manufacturing, regulation, customer concentration), Item 7 MD&A, Note 2 Segment Information, consolidated financial statements, liquidity. Local: output/GGG/sources/10-K/2026-02-17_ggg-20251226.htm.
• FY2024 Form 10-K (filed 2025-02-18) — segment recast, FY2024 revenue decline. .../2025-02-18_ggg-20241227.htm.
• FY2023 Form 10-K (filed 2024-02-20) — three-year trend, legacy segment structure. .../2024-02-20_ggg-20231229.htm.
• Q1-2026 Form 10-Q (period ended 2026-03-27) — organic-volume decomposition (−6%), segment bookings/backlog, price-vs-tariff. output/GGG/sources/10-Q/2026-04-22_ggg-20260327.htm.
• Q3-2025 / Q4-2025 / prior 10-Qs — quarterly organic trends. output/GGG/sources/10-Q/.
• DEF 14A proxy (filed 2026-04-02) — executive compensation metrics (Net Sales + Incentive EPS), incentive design, clawbacks, ownership. output/GGG/sources/DEF_14A/.
• Form 8-Ks — CFO succession/appointment of Sanjiv Gupta (2026-03-02); Valco Melton acquisition agreement (2026-05-21); director appointment Steven Hedlund (2026-06-15); dividend increase + new buyback authorization (2026-02-13); quarterly earnings releases (2024–2026); Corob (2024-09/11). output/GGG/sources/8-K/.
• Form 4 corpus (2024–2026) — insider transaction read: routine grants (code A); one director open-market purchase (A. Simon, 1,240 sh @ ~$80.53, code P, 2026-04-27). EDGAR.

Primary — Earnings-Call Transcripts (via ROIC.ai)

• Q1-2026 (call 2026-04-23) — “started slower in January”; organic −6%; FY2026 guide maintained (low-single organic); backlog conversion; tariffs ~$7M; Middle East risk; the “is it structural?” exchange.
• Q4-2025 (call 2026-01-27) — record Q4/FY; FY2026 guide set; One Graco FCF conversion; interim price increase.
• Q3-2025 (call 2025-10-23) — organic −2%; segment/geography detail (China positive; semi bookings +20%); pricing.

Quantitative Data Sources

• ROIC.ai — profitability ratios (ROE 31.6%, ROIC 18.5%, margins), enterprise value, valuation multiples (GGG, and comps NDSN/IEX/DOV), income-statement history; reconciled to filings (filings primary).
• AZI — five-year adjusted price CSV (event map); valuation-index own-history percentiles (P/E 24th, P/S 49th, P/B 0.02, composite 24.5th, BVPS $16.31); news feed (Wolfe downgrade). CSV local: output/GGG/2026-07-10/_scratch/GGG_price.csv.
• FactorsToday — factor loadings (Value/Quality/DividendYield positive, Momentum/Growth negative), stock-info (beta 0.78, alpha −0.19, RS −16% 12m), related-stocks (WTS/FELE/IEX/AIT), specific-vol (13%).
• EDGAR XBRL / edgar.sh — corpus enumeration; BVPS reconciliation ($2,653.9M equity / 165.15M shares = $16.07).

Secondary — Press & Third-Party

• Wolfe Research downgrade to Peer Perform, 2026-07-09 — investing.com.
• Valco Melton acquisition — BusinessWire, 2026-05-13; company IR release.
• Dividend increase + buyback authorization — Investing.com, 2026-02.
• Dividend-streak (Aristocrat, 25 years) — 24/7 Wall St. and analyst coverage, cross-checked to declared-DPS history.

Analytical Frameworks

• Greenwald & Kahn, Competition Demystified — moat taxonomy (scale-in-niche + customer captivity), market-share-stability and ROIC tests, EPV vs. asset/growth value.
• Marathon Asset Management (Edward Chancellor, ed.), Capital Returns — supply-side capital-cycle analysis, asset-growth anomaly, durable-pricing/agency-relationship framing.
• (via the repository’s investment-research-frameworks skill.)